Zhiyi Dong Selected Research

CL 387785

3/2022

EGFR inhibitor CL-387785 suppresses the progression of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyi Dong Research Topics

Disease

2	Adenocarcinoma of Lung 03/2022 - 12/2020
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Hypoxia (Hypoxemia) 03/2022
1	Body Weight (Weight, Body) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Adenocarcinoma 12/2020

Drug/Important Bio-Agent (IBA)

1	CL 387785IBA 03/2022
1	Sincalide FDA Link 03/2022
1	LuciferasesIBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	CholesterolIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Tyrosine Kinase InhibitorsIBA 12/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2020
1	Growth Factor ReceptorsIBA 12/2020

Therapy/Procedure

1	Therapeutics 12/2020